Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9809 |
High Similarity |
NPD7228 |
Approved |
0.974 |
High Similarity |
NPD6234 |
Discontinued |
0.961 |
High Similarity |
NPD4966 |
Approved |
0.961 |
High Similarity |
NPD4965 |
Approved |
0.961 |
High Similarity |
NPD4967 |
Phase 2 |
0.9416 |
High Similarity |
NPD37 |
Approved |
0.9207 |
High Similarity |
NPD7240 |
Approved |
0.875 |
High Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.8659 |
High Similarity |
NPD7199 |
Phase 2 |
0.8556 |
High Similarity |
NPD7680 |
Approved |
0.8488 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.8443 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8439 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8193 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8092 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8057 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8035 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8035 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7989 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7963 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7953 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7937 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7919 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7898 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7857 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7841 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7818 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7806 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7797 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7759 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7759 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7759 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7753 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7751 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.774 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7709 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7709 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7705 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7658 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7647 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7543 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7538 |
Intermediate Similarity |
NPD7827 |
Phase 1 |
0.7529 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7528 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7485 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7485 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7474 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7457 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7452 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7442 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7438 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7438 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7399 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7374 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7349 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7314 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7306 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7296 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7284 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7246 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7246 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD3750 |
Approved |
0.724 |
Intermediate Similarity |
NPD6782 |
Approved |
0.724 |
Intermediate Similarity |
NPD6781 |
Approved |
0.724 |
Intermediate Similarity |
NPD6777 |
Approved |
0.724 |
Intermediate Similarity |
NPD6778 |
Approved |
0.724 |
Intermediate Similarity |
NPD6779 |
Approved |
0.724 |
Intermediate Similarity |
NPD6780 |
Approved |
0.724 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7229 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7212 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7212 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7212 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7209 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD5402 |
Approved |
0.72 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7165 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7165 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7165 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7296 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7136 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7136 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7119 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7118 |
Intermediate Similarity |
NPD1511 |
Approved |
0.711 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7085 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7085 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7066 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7066 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7066 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7066 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7066 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7056 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7056 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7047 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7044 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7041 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7041 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7041 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7037 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7035 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7026 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7026 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7021 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7021 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7012 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7005 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7005 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7005 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7005 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7005 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7005 |
Intermediate Similarity |
NPD4582 |
Approved |
0.6994 |
Remote Similarity |
NPD5403 |
Approved |
0.6994 |
Remote Similarity |
NPD3764 |
Approved |
0.6994 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6985 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6982 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD6723 |
Discontinued |
0.6979 |
Remote Similarity |
NPD6535 |
Approved |
0.6979 |
Remote Similarity |
NPD6534 |
Approved |
0.6978 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6965 |
Remote Similarity |
NPD7801 |
Approved |
0.6962 |
Remote Similarity |
NPD1091 |
Approved |
0.6962 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD4004 |
Approved |
0.6954 |
Remote Similarity |
NPD4002 |
Approved |
0.6946 |
Remote Similarity |
NPD3748 |
Approved |
0.6946 |
Remote Similarity |
NPD7930 |
Approved |
0.6943 |
Remote Similarity |
NPD5126 |
Approved |
0.6943 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6941 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6939 |
Remote Similarity |
NPD3450 |
Approved |
0.6939 |
Remote Similarity |
NPD3452 |
Approved |
0.6914 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6914 |
Remote Similarity |
NPD3226 |
Approved |
0.6914 |
Remote Similarity |
NPD5736 |
Approved |
0.6911 |
Remote Similarity |
NPD2488 |
Approved |
0.6911 |
Remote Similarity |
NPD2490 |
Approved |
0.691 |
Remote Similarity |
NPD5353 |
Approved |
0.6905 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6898 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6895 |
Remote Similarity |
NPD6841 |
Approved |
0.6895 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6895 |
Remote Similarity |
NPD6842 |
Approved |
0.689 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6884 |
Remote Similarity |
NPD7999 |
Approved |
0.6879 |
Remote Similarity |
NPD5401 |
Approved |
0.6879 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD1357 |
Approved |
0.6875 |
Remote Similarity |
NPD4749 |
Approved |
0.6875 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6872 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6872 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6867 |
Remote Similarity |
NPD5735 |
Approved |
0.6864 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.686
|
Remote Similarity |
NPD5058 |
Phase 3 |